                         SEQUENCE LISTING

<110>  WELLSTEIN, Anton
 
<120>  COMPOSITIONS AND TREATMENTS OF METABOLIC DISORDERS USING FGF 
       BINDING PROTEIN 3 AND FGF19

<130>  036681-5014-WO

<150>  US 61/782,347
<151>  2013-03-14

<160>  5     

<170>  PatentIn version 3.5

<210>  1
<211>  258
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide - full length FGFBP3

<400>  1

Met Thr Pro Pro Lys Leu Arg Ala Ser Leu Ser Pro Ser Leu Leu Leu 
1               5                   10                  15      


Leu Leu Ser Gly Cys Leu Leu Ala Ala Ala Arg Arg Glu Lys Gly Ala 
            20                  25                  30          


Ala Ser Asn Val Ala Glu Pro Val Pro Gly Pro Thr Gly Gly Ser Ser 
        35                  40                  45              


Gly Arg Phe Leu Ser Pro Glu Gln His Ala Cys Ser Trp Gln Leu Leu 
    50                  55                  60                  


Leu Pro Ala Pro Glu Ala Ala Ala Gly Ser Glu Leu Ala Leu Arg Cys 
65                  70                  75                  80  


Gln Ser Pro Asp Gly Ala Arg His Gln Cys Ala Tyr Arg Gly His Pro 
                85                  90                  95      


Glu Arg Cys Ala Ala Tyr Ala Ala Arg Arg Ala His Phe Trp Lys Gln 
            100                 105                 110         


Val Leu Gly Gly Leu Arg Lys Lys Arg Arg Pro Cys His Asp Pro Ala 
        115                 120                 125             


Pro Leu Gln Ala Arg Leu Cys Ala Gly Lys Lys Gly His Gly Ala Glu 
    130                 135                 140                 


Leu Arg Leu Val Pro Arg Ala Ser Pro Pro Ala Arg Pro Thr Val Ala 
145                 150                 155                 160 


Gly Phe Ala Gly Glu Ser Lys Pro Arg Ala Arg Asn Arg Gly Arg Thr 
                165                 170                 175     


Arg Glu Arg Ala Ser Gly Pro Ala Ala Gly Thr Pro Pro Pro Gln Ser 
            180                 185                 190         


Ala Pro Pro Lys Glu Asn Pro Ser Glu Arg Lys Thr Asn Glu Gly Lys 
        195                 200                 205             


Arg Lys Ala Ala Leu Val Pro Asn Glu Glu Arg Pro Met Gly Thr Gly 
    210                 215                 220                 


Pro Asp Pro Asp Gly Leu Asp Gly Asn Ala Glu Leu Thr Glu Thr Tyr 
225                 230                 235                 240 


Cys Ala Glu Lys Trp His Ser Leu Cys Asn Phe Phe Val Asn Phe Trp 
                245                 250                 255     


Asn Gly 
        


<210>  2
<211>  232
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide - full length FGFBP3 without the signal 
       sequence

<400>  2

Arg Arg Glu Lys Gly Ala Ala Ser Asn Val Ala Glu Pro Val Pro Gly 
1               5                   10                  15      


Pro Thr Gly Gly Ser Ser Gly Arg Phe Leu Ser Pro Glu Gln His Ala 
            20                  25                  30          


Cys Ser Trp Gln Leu Leu Leu Pro Ala Pro Glu Ala Ala Ala Gly Ser 
        35                  40                  45              


Glu Leu Ala Leu Arg Cys Gln Ser Pro Asp Gly Ala Arg His Gln Cys 
    50                  55                  60                  


Ala Tyr Arg Gly His Pro Glu Arg Cys Ala Ala Tyr Ala Ala Arg Arg 
65                  70                  75                  80  


Ala His Phe Trp Lys Gln Val Leu Gly Gly Leu Arg Lys Lys Arg Arg 
                85                  90                  95      


Pro Cys His Asp Pro Ala Pro Leu Gln Ala Arg Leu Cys Ala Gly Lys 
            100                 105                 110         


Lys Gly His Gly Ala Glu Leu Arg Leu Val Pro Arg Ala Ser Pro Pro 
        115                 120                 125             


Ala Arg Pro Thr Val Ala Gly Phe Ala Gly Glu Ser Lys Pro Arg Ala 
    130                 135                 140                 


Arg Asn Arg Gly Arg Thr Arg Glu Arg Ala Ser Gly Pro Ala Ala Gly 
145                 150                 155                 160 


Thr Pro Pro Pro Gln Ser Ala Pro Pro Lys Glu Asn Pro Ser Glu Arg 
                165                 170                 175     


Lys Thr Asn Glu Gly Lys Arg Lys Ala Ala Leu Val Pro Asn Glu Glu 
            180                 185                 190         


Arg Pro Met Gly Thr Gly Pro Asp Pro Asp Gly Leu Asp Gly Asn Ala 
        195                 200                 205             


Glu Leu Thr Glu Thr Tyr Cys Ala Glu Lys Trp His Ser Leu Cys Asn 
    210                 215                 220                 


Phe Phe Val Asn Phe Trp Asn Gly 
225                 230         


<210>  3
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide - C-terminal FGFBP3

<400>  3

Leu Asp Gly Asn Ala Glu Leu Thr Glu Thr Tyr Cys Ala Glu Lys Trp 
1               5                   10                  15      


His Ser Leu Cys Asn Phe Phe Val Asn Phe Trp Asn Gly 
            20                  25                  


<210>  4
<211>  36
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide - Tat protein basic peptide motif 37-72

<400>  4

Cys Phe Ile Thr Lys Ala Leu Gly Ile Ser Tyr Gly Arg Lys Lys Arg 
1               5                   10                  15      


Arg Gln Arg Arg Arg Pro Pro Gln Gly Ser Gln Thr His Gln Val Ser 
            20                  25                  30          


Leu Ser Lys Gln 
        35      


<210>  5
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide - Tat protein residues 48-57

<400>  5

Gly Arg Lys Lys Arg Arg Gln Arg Arg Arg 
1               5                   10  


